Reliable Clinical Research LLC

1. ACADIA Pharmaceuticals Inc $2,232,189 387 payments
2. Teva Pharmaceuticals USA, Inc. $662,211 41 payments
3. Neurocrine Biosciences, Inc. $566,225 106 payments
4. Allergan Inc. $408,060 29 payments
5. Janssen Research & Development, LLC $404,949 55 payments
6. Boehringer Ingelheim Pharmaceuticals, Inc. $190,867 5 payments
7. Chiesi USA, Inc. $89,750 33 payments
8. Sanofi US Services Inc. $86,444 19 payments
9. Dr.Reddy's Laboratories,Inc. $62,305 10 payments
10. Akebia Therapeutics Inc $60,772 71 payments

1. Acp-204-006 $1,114,071 240 payments
2. A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia $662,211 41 payments
3. Acp-103-046 $468,885 27 payments
4. A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso $365,515 45 payments
5. A Double-Blind, Placebo-Controlled Study of Cariprazine As Adjunctive Therapy in Major Depressive Disorder $339,662 16 payments
6. Acp-204-008 $326,345 95 payments
7. The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine $233,992 14 payments
8. PoC in Prevention of Relapse $190,867 5 payments
9. Acp-103-047 $162,983 12 payments
10. Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia $155,170 39 payments

1. Patient care $6,299 8 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.